FA
Fabiana Alves

Publications (10)

Severe visceral leishmaniasis in Ethiopia: outcomes, co-infections and mortality in a prospective real-world cohort
Article scientifique · 2025
The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities
Article scientifique · 2025
A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan—A landmark trial by the Mycetoma Research Center
Article scientifique · 2025
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform
Article scientifique · 2024
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study
Article scientifique · 2023
Clinical features and treatment outcomes of visceral leishmaniasis patients admitted to three centers in Oromia, Ethiopia
Article scientifique · 2020
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
Article scientifique · 2019
Effectiveness of combination therapy with liposomal amphotericin B and miltefosine for visceral leishmaniasis in HIV coinfection: DNDi/MSF strategy for policy change in East Africa
Autre document · 2018
Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis
Article scientifique · 2018
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
Article scientifique · 2016

Domaines principaux

Sciences de la santé9

Statistiques

Consultations22
Téléchargements0